Solid Form Screening

Solid form screening plays a critical role in drug development by identifying the optimal physical form of an active pharmaceutical ingredient to ensure successful formulation and long-term performance. Differences in solid-state properties—such as polymorphs, salts, and cocrystals—can significantly impact a drug’s solubility, stability, and manufacturability, making early characterization essential. A structured, tiered screening approach enables developers to evaluate multiple crystallization conditions and solvent systems, helping uncover the most suitable form for development. Advanced analytical techniques, including XRPD, DSC, and microscopy, provide detailed insight into material properties and behavior under varying conditions. These data not only support formulation design but also inform regulatory strategy, intellectual property development, and lifecycle management. By integrating solid form screening early in the process, developers can reduce risk and improve the likelihood of successful, scalable pharmaceutical development.